Physician profile
James Thomas Torey
NPI 1841341161
$55,669.00
in general payments reported to CMS, 2019-2025
20 companies · $21K in 2025
The $21K reported for 2025 was more than what 99% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,245 · 2022: $14K · 2023: $13K · 2024: $6,210 · 2025: $21K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $14K · Consulting Fee: $12K · Travel and Lodging: $6,723 · Food and Beverage: $3,404 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,110 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,500 · Grant: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $14,478.64 |
| Consulting Fee | $12,117.50 |
| Travel and Lodging | $6,723.38 |
| Food and Beverage | $3,404.43 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,110.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,500.00 |
| Grant | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $30,512.08 | 2021-2025 | US Eq Undivided, Igt Devices Undivided, (Bq9) Coronary Ivus |
| Shockwave Medical, INC | $9,707.12 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cathworks, INC. | $7,160.40 | 2022 | |
| Abbott Laboratories | $4,139.60 | 2021-2025 | Coroflow, Dragonfly Opstar, Pressurewire |
| Terumo Medical Corporation | $2,200.00 | 2023 | |
| Stryker Corporation | $664.53 | 2025 | Clottriever Bold Catheter, Flowtriever |
| Kestra Medical Technology Services, INC. | $338.84 | 2024-2025 | Assure Wcd |
| Boston Scientific Corporation | $141.30 | 2021-2022 | |
| Cardiovascular Systems INC. | $136.29 | 2021 | |
| Chiesi USA, INC. | $133.15 | 2023-2025 | Kengreal, Cleviprex |
| Cardiva Medical, INC. | $115.79 | 2023-2025 | Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Vvcs 6-12f |
| Boehringer Ingelheim Pharmaceuticals, INC. | $115.50 | 2024 | Jardiance |
| Teleflex LLC | $72.41 | 2023-2025 | Guideliner, Turnpike |
| Inari Medical, INC. | $50.08 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Janssen Pharmaceuticals, INC | $48.97 | 2024 | Xarelto |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Imperative Care, INC | $39.96 | 2025 | Symphony Catheter |
| Pfizer INC. | $38.85 | 2024 | |
| Cordis US Corp. | $35.32 | 2024 | Precise Pro Rx, Mynxgrip |
| E.R. Squibb & Sons, L.L.C. | $18.81 | 2024 | Camzyos |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Torey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.